SCHEMBL10041685

SCHEMBL10041685

Clc1ccc(Cl)c(-c2ncccc2-c2nc3ccccc3[nH]2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.59
ALDH1A1 P00352 7/20 0.59
RAB9A P51151 7/20 0.59
KDM4E B2RXH2 6/20 0.59
GPR55 Q9Y2T6 1/20 0.59
CDK1 P06493 1/20 0.54
CDK2 P24941 1/20 0.54
MKNK1 Q9BUB5 1/20 0.54
MKNK2 Q9HBH9 1/20 0.54
SMN1; SMN2 Q16637 4/20 0.51
NPSR1 Q6W5P4 3/20 0.51
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
METAP2 P50579 2/20 0.49
METAP1 P53582 2/20 0.49
AMY1A P0DUB6 1/20 0.49
CBFB Q13951 1/20 0.49
HTT P42858 2/20 0.48
HPGD P15428 4/20 0.46
HSD17B10 Q99714 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19960361 0.88 NPC1 (0.72) NPC1ALDH1A1RAB9AKDM4EGPR55
SCHEMBL12861171 0.85 ALDH1A1 (0.71) NPC1ALDH1A1RAB9AKDM4EGPR55
SCHEMBL10041681 0.85 KDM4E (0.56) NPC1ALDH1A1RAB9AKDM4EGPR55
SCHEMBL10041654 0.84 ALDH1A1 (0.69) NPC1ALDH1A1RAB9AKDM4EGPR55
SCHEMBL14644256 0.81 NPC1 (0.57) NPC1ALDH1A1RAB9AKDM4EGPR55
SCHEMBL6530312 0.81 CDK1 (0.69) NPC1ALDH1A1RAB9AKDM4EGPR55
SCHEMBL18891696 0.80 NPC1 (0.68) NPC1ALDH1A1RAB9AKDM4EGPR55
SCHEMBL10041699 0.80 ALDH1A1 (0.72) NPC1ALDH1A1RAB9AKDM4EGPR55
SCHEMBL10041666 0.80 ALDH1A1 (0.72) NPC1ALDH1A1RAB9AKDM4EGPR55
SCHEMBL28036109 0.80 CDK1 (0.68) NPC1ALDH1A1RAB9AKDM4EGPR55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9139562-B2 Nitrogen-containing heterocyclic compound and organic electronic device using the same LG CHEM, LTD. (KR) 2015-09-22 US disclosed
US-9139562-B2 Nitrogen-containing heterocyclic compound and organic electronic device using the same LG CHEM, LTD. (KR) 2015-09-22 US disclosed
US-20120007069-A1 NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME LG CHEM, LTD. (KR) 2012-01-12 US disclosed
US-20120007069-A1 NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME LG CHEM, LTD. (KR) 2012-01-12 US disclosed
US-20110127513-A1 NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME LG CHEM, LTD. (KR) 2011-06-02 US disclosed
US-20110127513-A1 NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME LG CHEM, LTD. (KR) 2011-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120007069-A1 NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME VDAC2, VDAC1, VDAC3 NPC1 3498/4885ALDH1A1 2949/4885RAB9A 2658/4885
US-20110127513-A1 NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME VDAC2, VDAC1, VDAC3 NPC1 3498/4885ALDH1A1 2949/4885RAB9A 2658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.